Clinical trial
Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous…
NCT00003255 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003255 |
|---|---|
| Title | Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia |
| Official title | Phase II Study of Continuous Infusion Carboplatin and Topotecan in the Treamtment of Relapsed Acute Myelogenous Leukemia (AML) |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | carboplatin, topotecan hydrochloride |
| Enrollment | 38 |
| Start date | Nov 1, 1999 |
| Primary completion | Dec 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | May 20, 2004 |
| Last update posted | Jul 12, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: